Work

An Unexpected Partnership: Histone Deacetylase 6 and Glutaminase Inhibition Provide an Opportunity to Overcome Resistance in KRAS and LKB1 Co-mutant Lung Tumors

Year: 2023

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.04.012

Authors: Brandon Nadres, Milica Momcilovic, David B. Shackelford, Aaron Lisberg

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: LUNGevity Foundation, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Jazz Pharmaceuticals, Novocure, Calithera Biosciences, MorphoSys, National Institutes of Health, Daiichi Sankyo Europe

OpenAlex ID: W4381436009

FWCI: 0.161

Cites: 28

Cited by: 1

Related to: 10